BIOVECTRA

BIOVECTRA is a leading global, full-service Contract Development and Manufacturing Organization (CDMO) specializing in biologics, small molecules, pDNA/mRNA manufacturing, HPAPIs, and bioreagents. With expertise in both microbial fermentation and chemical synthesis, BIOVECTRA excels at tackling the complex challenges presented by today's evolving development pipeline. BIOVECTRA's bold vision, coupled with a passion and commitment to turning that vision into reality, forms the core of the organization. The primary address for BIOVECTRA is 11 Aviation Avenue, Charlottetown, PE C1e 0A1, CA.

BIOVECTRA is a forward-thinking, North American CDMO pharmaceutical company offering clinical-to-commercial scale production capabilities for synthetic small molecules, fermented small molecules, highly potent APIs, biologics, and bioreagents. Flexibility, creativity, and a dedication to process optimization are central to BIOVECTRA's method and process development, as well as its quality and compliance efforts. The company ensures programs advance on time, delivering the highest quality outcomes under experienced project management.

BIOVECTRA is dedicated to innovation and excellence in the biotechnology sector. BIOVECTRA continues to expand its capabilities and service offerings to meet the growing needs of its global client base. We invite the manager of BIOVECTRA to create a customized and exclusive company showcase and product listing on our platform.